Matches in SemOpenAlex for { <https://semopenalex.org/work/W2399838706> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W2399838706 abstract "Objective: The equilibrium between apoptotic and survival pathways determines the fate of cells. Dysregulation in any one mechanism often leads to cancer. The present study was designed to determine the crosstalk between TRAIL and NF-kappaB pathways through study of the much controversial role of DcR2 in the induction of NF-kappaB. Methodology: A total of 50 epithelial ovarian tissue samples were used for immunohistochemical staining of DcR2 and NF-kappaB (p65) proteins along with the other players of TRAIL pathway including DR4, DR5, DcR1, FLIP and TRAIL. Correlations were drawn and survival analysis was performed using Kaplan Meier9s method. Results: A total of 72% ovarian carcinomas showed positive DR4 expression, 68% showed positive DR5 expression, 42% showed positive DcR1 expression, 48% showed positive DcR2 expression, 44% had positive FLIP expression, 46% had positive TRAIL expression in epithelium while 28% had positive TRAIL expression in stroma. NF-kappaB was positive in 46% of the tissue samples. A strong but non-significant correlation was seen between DcR2 and NF-kappaB expression. Interestingly a similar correlation was also found between DR4 and NF-kappaB expression. Survival analysis showed better survival for patients with positive NF-kappaB expression as compared to negative expression. Conclusion: Coexpression of DcR2 and NF-kappaB suggests a potential therapeutic approach of targeting NF-kappaB through TRAIL pathway by using anti-DcR2 antibodies. However, the study may be elaborated with increased sample size to get significant results. Note: This abstract was not presented at the conference. Citation Format: Mariam Anees, Umaima Batool, Sidra Bukhari, Sohail Yousaf. Regulation of TRAIL and NF-kappaB pathways in ovarian cancer. [abstract]. In: Proceedings of the AACR Special Conference on Advances in Ovarian Cancer Research: Exploiting Vulnerabilities; Oct 17-20, 2015; Orlando, FL. Philadelphia (PA): AACR; Clin Cancer Res 2016;22(2 Suppl):Abstract nr A16." @default.
- W2399838706 created "2016-06-24" @default.
- W2399838706 creator A5001292734 @default.
- W2399838706 creator A5013926040 @default.
- W2399838706 creator A5057883638 @default.
- W2399838706 creator A5091014933 @default.
- W2399838706 date "2016-01-15" @default.
- W2399838706 modified "2023-09-25" @default.
- W2399838706 title "Abstract A16: Regulation of TRAIL and NF-kappaB pathways in ovarian cancer." @default.
- W2399838706 doi "https://doi.org/10.1158/1557-3265.ovca15-a16" @default.
- W2399838706 hasPublicationYear "2016" @default.
- W2399838706 type Work @default.
- W2399838706 sameAs 2399838706 @default.
- W2399838706 citedByCount "0" @default.
- W2399838706 crossrefType "proceedings-article" @default.
- W2399838706 hasAuthorship W2399838706A5001292734 @default.
- W2399838706 hasAuthorship W2399838706A5013926040 @default.
- W2399838706 hasAuthorship W2399838706A5057883638 @default.
- W2399838706 hasAuthorship W2399838706A5091014933 @default.
- W2399838706 hasConcept C104317684 @default.
- W2399838706 hasConcept C121608353 @default.
- W2399838706 hasConcept C126322002 @default.
- W2399838706 hasConcept C143998085 @default.
- W2399838706 hasConcept C190283241 @default.
- W2399838706 hasConcept C204232928 @default.
- W2399838706 hasConcept C2777730290 @default.
- W2399838706 hasConcept C2780427987 @default.
- W2399838706 hasConcept C2988405389 @default.
- W2399838706 hasConcept C3019894029 @default.
- W2399838706 hasConcept C502942594 @default.
- W2399838706 hasConcept C52124034 @default.
- W2399838706 hasConcept C55493867 @default.
- W2399838706 hasConcept C6856738 @default.
- W2399838706 hasConcept C71924100 @default.
- W2399838706 hasConcept C86803240 @default.
- W2399838706 hasConceptScore W2399838706C104317684 @default.
- W2399838706 hasConceptScore W2399838706C121608353 @default.
- W2399838706 hasConceptScore W2399838706C126322002 @default.
- W2399838706 hasConceptScore W2399838706C143998085 @default.
- W2399838706 hasConceptScore W2399838706C190283241 @default.
- W2399838706 hasConceptScore W2399838706C204232928 @default.
- W2399838706 hasConceptScore W2399838706C2777730290 @default.
- W2399838706 hasConceptScore W2399838706C2780427987 @default.
- W2399838706 hasConceptScore W2399838706C2988405389 @default.
- W2399838706 hasConceptScore W2399838706C3019894029 @default.
- W2399838706 hasConceptScore W2399838706C502942594 @default.
- W2399838706 hasConceptScore W2399838706C52124034 @default.
- W2399838706 hasConceptScore W2399838706C55493867 @default.
- W2399838706 hasConceptScore W2399838706C6856738 @default.
- W2399838706 hasConceptScore W2399838706C71924100 @default.
- W2399838706 hasConceptScore W2399838706C86803240 @default.
- W2399838706 hasLocation W23998387061 @default.
- W2399838706 hasOpenAccess W2399838706 @default.
- W2399838706 hasPrimaryLocation W23998387061 @default.
- W2399838706 hasRelatedWork W1040485 @default.
- W2399838706 hasRelatedWork W12585302 @default.
- W2399838706 hasRelatedWork W14542699 @default.
- W2399838706 hasRelatedWork W3320906 @default.
- W2399838706 hasRelatedWork W5167578 @default.
- W2399838706 hasRelatedWork W5363639 @default.
- W2399838706 hasRelatedWork W7869943 @default.
- W2399838706 hasRelatedWork W8868882 @default.
- W2399838706 hasRelatedWork W9607138 @default.
- W2399838706 hasRelatedWork W4119864 @default.
- W2399838706 isParatext "false" @default.
- W2399838706 isRetracted "false" @default.
- W2399838706 magId "2399838706" @default.
- W2399838706 workType "article" @default.